CIK 0001697862 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in P7 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-19 | 6-K | FORM 6-K | 2026-10-19 |
| 2026-10-08 | 6-K | FORM 6-K | 2026-10-08 |
| 2026-09-29 | 6-K | FORM 6-K | 2026-09-29 |
| 2026-08-27 | 6-K | 6-K | 2026-08-27 |
| 2026-08-27 | SC TO-T/A | SC TO-T/A | |
| 2026-08-19 | SC TO-T/A | SC TO-T/A | |
| 2026-08-17 | 6-K | FORM 6-K | 2026-08-17 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | SC TO-T/A | SC TO-T/A | |
| 2026-08-06 | SC TO-T | SC TO-T | |
| 2026-08-03 | 6-K | FORM 6-K | 2026-08-03 |
| 2026-07-28 | SC TO-C | SC TO-C | |
| 2026-07-27 | SC TO-C | SC TO-C | |
| 2026-07-27 | 6-K | FORM 6-K | 2026-07-27 |
| 2026-07-23 | 6-K | 6-K | 2026-06-30 |
| 2026-06-23 | 6-K | FORM 6-K | 2026-06-23 |
| 2026-06-03 | 6-K | FORM 6-K | 2026-06-03 |
| 2026-05-11 | 6-K | FORM 6-K | 2026-05-08 |
| 2026-05-07 | 6-K | 6-K | 2026-03-31 |
| 2026-05-06 | 6-K | FORM 6-K | 2026-05-06 |
| 2026-05-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-20 | 6-K | FORM 6-K | 2026-04-20 |
| 2026-03-20 | 6-K | FORM 6-K | 2026-03-20 |
| 2026-03-19 | 20-F | 20-F | 2025-12-31 |
| 2026-03-19 | 6-K | 6-K | 2025-12-31 |
Forms on file (last 1,000): 6-K 182, SC 13G/A 22, 424B5 12, CORRESP 10, 20-F 9, UPLOAD 9, SC 13G 7, SCHEDULE 13G/A 6. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ARGX (0.002 USD), /gw/filings/filings?ticker=ARGX&form=8-K, /gw/filings/facts?ticker=ARGX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange